Dose-Effect Relationship of Chitosan and Danshen Combined Injection for Fallopian Tube Recanalizatio
Phase 1
Recruiting
- Conditions
- fallopian tube obstructive infertility
- Registration Number
- ITMCTR2200005815
- Lead Sponsor
- Guangzhou panyu central hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
(1) females of childbearing age (between 22 and 45 years), and (2) a Fallopian tube isthmus or interstitial obstruction diagnosed without adhesions of the fimbriated tubal extremity, determined on laparoscopic examination or salpingography.
Exclusion Criteria
(1) pelvic infection, congenital physiological defects or malformations, infertility caused by genetic factors, endocrine factors (follicle-stimulating hormone [FSH] or luteinizing hormone [LH] or other hormones) or immune factors, (2) endometriosis, uterine myoma, uterine hypoplasia, tubal ligation, or pelvic tuberculosis, (3) male partners were diagnosed with reproductive dysfunction.(4)Allergic to the drugs used(5)not prescribed medication treatment or incomplete information.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tubal patency rates;Pregnancy rates;
- Secondary Outcome Measures
Name Time Method